enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Vilazodone - Wikipedia

    en.wikipedia.org/wiki/Vilazodone

    Vilazodone was approved for medical use in the United States in 2011 [1] and in Canada in 2018. [8] In 2019, it was the 334th most commonly prescribed medication in the United States, with more than 900 thousand prescriptions. [9] The drug lost patent protection in June 2022 for adults and in July 2023 for pediatrics. [10]

  3. The main discussion of these abbreviations in the context of drug prescriptions and other medical prescriptions is at List of abbreviations used in medical prescriptions. Some of these abbreviations are best not used, as marked and explained here.

  4. Perindopril - Wikipedia

    en.wikipedia.org/wiki/Perindopril

    Each tablet contains 2, 4, or 8 mg of the tert-butylamine salt of perindopril. Perindopril is also available under the trade name Coversyl Plus, containing 4 mg of perindopril combined with 1.25 mg indapamide, a thiazide-like diuretic. In Australia, each tablet contains 2.5, 5, or 10 mg of perindopril arginine.

  5. Linagliptin - Wikipedia

    en.wikipedia.org/wiki/Linagliptin

    Linagliptin, sold under the brand name Tradjenta among others, is a medication used to treat type 2 diabetes (but not type 1) in conjunction with exercise and diet. [8] [9] It is generally less preferred than metformin and sulfonylureas as an initial treatment. [8] [10] It is taken by mouth. [8] Common side effects include inflammation of the ...

  6. Nomegestrol acetate - Wikipedia

    en.wikipedia.org/wiki/Nomegestrol_acetate

    [1] [2] Steady-state concentrations of NOMAC are achieved after five days of repeated administration. [1] As Zoely (2.5 mg/day NOMAC), the average circulating concentrations of NOMAC are 4.5 ng/mL at steady-state, with minimum and maximum concentrations of 3.1 ng/mL and 12.3 ng/mL, respectively. [2] The medication is eliminated via urine and ...

  7. Ipragliflozin - Wikipedia

    en.wikipedia.org/wiki/Ipragliflozin

    Ipragliflozin (INN, [2]: 69 trade names Suglat) is a pharmaceutical drug for treatment of type 2 diabetes. Ipragliflozin, jointly developed by Astellas Pharma and Kotobuki Pharmaceutical, was approved in Japan on January 17, 2014, [3] and in Russia on May 22, 2019. [4] Ipragliflozin is a Sodium/glucose cotransporter 2 (SGLT2) inhibitor . [5]

  8. Emtricitabine/tenofovir - Wikipedia

    en.wikipedia.org/wiki/Emtricitabine/tenofovir

    [5] [6] It contains the antiretroviral medications emtricitabine and tenofovir disoproxil. [7] For treatment, it must be used in combination with other antiretroviral medications. [7] [8] For prevention before exposure, in those who are at high risk, it is recommended along with safer sex practices. [7] It does not cure HIV/AIDS. [5]

  9. Vildagliptin - Wikipedia

    en.wikipedia.org/wiki/Vildagliptin

    Vildagliptin is indicated, as an adjunct to diet and exercise, to improve glycemic control in adults with type 2 diabetes as monotherapy in people in whom metformin is inappropriate due to contraindications or intolerance; and in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycemic control.